Status:

COMPLETED

Respiratory Muscles After Hospitalisation for COVID-19

Lead Sponsor:

RWTH Aachen University

Conditions:

Covid19

Diaphragm Injury

Eligibility:

All Genders

18+ years

Brief Summary

Fatigue and exercise intolerance after survived COVID-19-infection might be related to weakness of the respiratory muscles especially following invasive mechanical ventilation in the Intensive Care Un...

Detailed Description

The aim of the present project is to comprehensively measure respiratory muscle function and strength in patients who survived a hospitalisation for a severe COVID-19-infection (25 with a severe cours...

Eligibility Criteria

Inclusion

  • 50 patients with survived COVID-19-infection (25 with a severe course requiring mechanical ventilation in the intensive care unit, 25 with a moderate-severe course requiring administration of supplemental oxygen only, respectively)
  • Patients aged at least 18 years, who are mentally and physically able to consent and participate into the study

Exclusion

  • Diagnosis of another disease, which causes a permanent increase in carbon dioxide level in the blood (chronic hypercapnia) or a permanent combined lung weakness (particularly a neuromuscular disease)
  • Body-mass-index (BMI) \>40
  • Expected absence of active participation of the patient in study-related measurements
  • Alcohol or drug abuse
  • Metal implant in the body that is not MRI compatible (NON MRI compatible pacemaker, implantable defibrillator, cervical implants, e.g. brain pacemakers etc.)
  • Slipped disc
  • Epilepsy
  • Bound to a wheel chair
  • Patients who are mentally and physically unable to consent and participate into the study
  • Patients in an interdependence or with an employment contract with the principal investigator, Co-PI or his deputy.
  • Emergency hospital stay in the last 4 weeks preceding the day of the measurements

Key Trial Info

Start Date :

June 1 2021

Trial Type :

OBSERVATIONAL

Allocation :

ACTUAL

End Date :

November 20 2023

Estimated Enrollment :

50 Patients enrolled

Trial Details

Trial ID

NCT04854863

Start Date

June 1 2021

End Date

November 20 2023

Last Update

November 24 2023

Active Locations (1)

Enter a location and click search to find clinical trials sorted by distance.

Page 1 of 1 (1 locations)

1

Jens Spiesshoefer

Aachen, North Rhine-Westphalia, Germany